GeneBio Systems
IFNb ELISA kit (Human)
IFNb ELISA kit (Human)
SKU:SEA222Hu
Couldn't load pickup availability
Size: 96Tests
# of Times Cited in literature: 17
Prepare Time: 1-3 days(please inquire for mutiple units)
Target Name: IFNb
Target Full Name: Interferon Beta
Alternative Names: IFNB1; IFN-B; IFB; IFF; IFNB; Interferon Beta 1 Fibroblast
Target Species: Human
Uniprot: P01574
Gene ID: 3456
Featured Series: SE kit
Featured Series Function: Detects protein (regular version)
Specificity: Reactive with Human IFNb / Interferon Beta
Method: Colormetric
Detection principle: Double-antibody Sandwich
Detection range: 7.8-500pg/mL
Sensitivity: 3.0pg/mL
Assay Time: 3h
Sample Size: 100uL
Recommended/Predicted Sample Types: Serum, Plasma, Tissue Homogenates, Cell Lysates, Cell Culture Supernates and other Biological Fluids
Assay Precision: Intra-Assay: CV<10%, Inter-Assay: CV<12%
Reproducibility test menthod: Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Interferon Beta (IFNb) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Interferon Beta (IFNb) were tested on 3 different plates, 8 replicates in each plate. CV(%) = SD/meanX100
Storage: 4°C for 1 month/ -20°C for long-term(One year within shelf life)
Shelf-life: 12 months
Specificity: This assay has high sensitivity and excellent specificity for detection of Interferon Beta (IFNb). No significant cross-reactivity or interference between Interferon Beta (IFNb) and analogues was observed.
Stability: The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition. To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Assay procedure summary: 1. Prepare all reagents, samples and standards; 2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C; 3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C; 4. Aspirate and wash 3 times; 5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C; 6. Aspirate and wash 5 times; 7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C; 8. Add 50µL Stop Solution. Read at 450nm immediately.
Test principle: The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Interferon Beta (IFNb). Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody specific to Interferon Beta (IFNb). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Interferon Beta (IFNb), biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Interferon Beta (IFNb) in the samples is then determined by comparing the O.D. of the samples to the standard curve.
Research Area: Cytokine;Tumor immunity;Infection immunity;
References Citing This Product: Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKε and DDX3.
Impaired TLR3/IFN-β signaling in monocyte-derived dendritic cells from patients with acute-on-chronic hepatitis B liver failure: Relevance to the severity of liver damage
Training Modifies Innate Immune Responses in Blood Monocytes and in Pulmonary Alveolar Macrophages
Mannan binding lectin attenuates double-stranded RNA-mediated TLR3 activation and innate immunity
MicroRNA-30e* Suppresses Dengue Virus Replication by Promoting NF-κB–Dependent IFN Production
Complexes of DNA with the Antimicrobial Peptide LL37 Augment NK Cell Functions by Inducing Type I Interferon Production from Circulating Monocytes and Plasmacytoid Predendritic Cells
siRNA Targeting the 2A pro Genomic Region Prevents Enterovirus 71 Replication In Vitro
Cellular uptake of exogenous calcineurin B is dependent on TLR4/MD2/CD14 complexes, and CnB is an endogenous ligand of TLR4
Effects of IRF1 and IFN-β interaction on the M1 polarization of macrophages and its antitumor function
Host miR-146a promotes replication of human cytomegalovirus by suppressing type I IFN response in MRC-5 cells
MicroRNA-548j inhibits type I interferon production by targeting ZBTB11 in patients with chronic hepatitis B
Zika virus elicits inflammation to evade antiviral response by cleaving cGAS via NS1‐caspase‐1 axis
Evaluation of serum interferons in patients with age-related macular degeneration
Serodiagnosis of Human Bocavirus 1 Infection among Hospitalised Children with Lower Respiratory Tract Infection in Latvia
Scavenger receptor A impairs interferon response to HBV infection by limiting TRAF 3 ubiquitination through recruiting OTUB 1
Transferrin-dependent crosstalk between the intestinal tract and commensal microbes contributes for immune tolerance
Anti‐IFN‐α/‐ω neutralizing antibodies from COVID‐19 patients correlate with downregulation of IFN response and laboratory biomarkers of disease severity
